Myeloproliferative neoplasm classification: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 6: Line 6:


===WHO Classification of Myeloproliferative Neoplasms (MPN)===
===WHO Classification of Myeloproliferative Neoplasms (MPN)===
* Chronic myelogenous leukemia, BCR-ABL1–positive
* [[Chronic myelogenous leukemia]], [[BCR]]-[[ABL1]]–positive
* Chronic neutrophilic leukemia
* [[Chronic neutrophilic leukemia]]
* Polycythemia vera
* [[Polycythemia vera]]
* Primary myelofibrosis
* [[Primary myelofibrosis]]
* Essential thrombocythemia
* [[Essential thrombocythemia]]
* Chronic eosinophilic leukemia, not otherwise specified
* [[Chronic eosinophilic leukemia]], not otherwise specified
* Mastocytosis
* [[Mastocytosis]]
* Myeloproliferative neoplasms, unclassifiable
* Myeloproliferative neoplasms, unclassifiable<ref>{{Cite journal| doi = 10.1182/blood-2009-03-209262| issn = 1528-0020| volume = 114| issue = 5| pages = 937–951| last1 = Vardiman| first1 = James W.| last2 = Thiele| first2 = Jüergen| last3 = Arber| first3 = Daniel A.| last4 = Brunning| first4 = Richard D.| last5 = Borowitz| first5 = Michael J.| last6 = Porwit| first6 = Anna| last7 = Harris| first7 = Nancy Lee| last8 = Le Beau| first8 = Michelle M.| last9 = Hellström-Lindberg| first9 = Eva| last10 = Tefferi| first10 = Ayalew| last11 = Bloomfield| first11 = Clara D.| title = The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes| journal = Blood| date = 2009-07-30| pmid = 19357394}}</ref>


==References==
==References==

Revision as of 14:59, 2 April 2015

Myeloproliferative Neoplasm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating myeloproliferative neoplasm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myeloproliferative neoplasm classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myeloproliferative neoplasm classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myeloproliferative neoplasm classification

on Myeloproliferative neoplasm classification

Myeloproliferative neoplasm classification in the news

Blogs on Myeloproliferative neoplasm classification

Directions to Hospitals Treating Myeloproliferative neoplasm

Risk calculators and risk factors for Myeloproliferative neoplasm classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Classification

WHO Classification of Myeloproliferative Neoplasms (MPN)

References

  1. Vardiman, James W.; Thiele, Jüergen; Arber, Daniel A.; Brunning, Richard D.; Borowitz, Michael J.; Porwit, Anna; Harris, Nancy Lee; Le Beau, Michelle M.; Hellström-Lindberg, Eva; Tefferi, Ayalew; Bloomfield, Clara D. (2009-07-30). "The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes". Blood. 114 (5): 937–951. doi:10.1182/blood-2009-03-209262. ISSN 1528-0020. PMID 19357394.